Austin M. Faught, PhD
Austin M. Faught, PhD

Austin M. Faught, PhD

Assistant Member, St. Jude Faculty



BA – Kenyon College, Gambier, Ohio
PhD – M.D. Anderson Cancer Center UT Health Graduate School of Biomedical Sciences, Houston, Texas
Residency – Duke University Medical Center, Durham, North Carolina
Postdoctoral Research Fellowship – University of Colorado Denver-Anschutz Medical Campus, Denver, Colorado

Research Interests

  • Relationship between proton LET and late effects in pediatric patients
  • Development and implementation of a Monte Carlo second check system for proton therapy dose calculations
  • Implementation of adaptive therapy to proton therapy
  • Computational research

Selected Publications

Faught AM, et al. Development of a Monte Carlo Multiple Source Model for Inclusion in a Dose Calculation Auditing Tool. Med Phys 2017 (in press).

Faught AM, et al. Development of a Flattening Filter Free Multiple Source Model for Use as an Independent, Monte Carlo, Dose Calculation, Quality Assurance Tool for Clinical Trials. Med Phys 2017 (in press).

Faught AM, et al. Evaluating the toxicity reduction with CT-ventilation functional avoidance radiotherapy. IJROBP 99(2):325-333, 2017.

Faught AM, et al. Evaluating which dose-function metrics are most critical for functional-guided radiotherapy with CT ventilation imaging. IJROBP 99(1):202-209, 2017.

Waxweiler T, Schubert L, Diot Q, Faught AM, Stuhr K, Castillo R, Castillo E, Guerrero T, Rusthoven C, Gaspar L, Kavanagh B, Miften M, Vinogradskiy Y. A complete 4DCT-ventilation functional avoidance virtual trial: Developing strategies for prospective clinical trials. JACMP 18(3):144-152, 2017.

Faught AM, Adamson J. Protocol for improved flood field calibration of TrueBeam FFF cine imaging. JACMP 18(1):265-268, 2017.

Faught AM, et al. Re-examining TG-142 recommendations in light of modern techniques for linear accelerator based radiosurgery. Med Phys 43:5437, 2016.

Kry S, Molineu A, Kerns J, Faught AM, Huang J, Tonigan J, Alvarez P, Stingo F, Followill D. Institutional patient-specific IMRT QA does not predict unacceptable plan delivery. IJROBP 90(5):1195-1201, 2014.

Faught AM, et al. Development of a modified head, quality assurance phantom for use in stereotactic radiosurgery trials. JACMP 14(4):206-215, 2013.

Last update: September 2017